Literature DB >> 20430965

The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/API2-MALT1 translocation in MALT lymphomas is not.

Albert G Tsai, Zhengfei Lu, Michael R Lieber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20430965      PMCID： PMC2867271          DOI： 10.1182/blood-2010-01-265157

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation.

Authors:  M Baens; B Maes; A Steyls; K Geboes; P Marynen; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity.

Authors:  Albert G Tsai; Haihui Lu; Sathees C Raghavan; Markus Muschen; Chih-Lin Hsieh; Michael R Lieber
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

3.  t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks.

Authors:  Hongxiang Liu; Rifat A Hamoudi; Hongtao Ye; Agnes Ruskone-Fourmestraux; Ahmet Dogan; Peter G Isaacson; Ming-Qing Du
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

4.  The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.

Authors:  Eva Maria Murga Penas; Evelyne Callet-Bauchu; Hongtao Ye; Sophie Gazzo; Françoise Berger; Georgia Schilling; Nadine Albert-Konetzny; Eik Vettorazzi; Gilles Salles; Iwona Wlodarska; Ming-Qing Du; Carsten Bokemeyer; Judith Dierlamm
Journal:  Blood       Date:  2009-11-25       Impact factor: 22.113

5.  Molecular characterization of the genomic breakpoint junction in the t(11;18) (q21;q21) translocation of a gastric MALT lymphoma.

Authors:  Y Sato; Y Akiyama; T Tanizawa; T Shibata; K Saito; S Mori; R Kamiyama; Y Yuasa
Journal:  Biochem Biophys Res Commun       Date:  2001-01-12       Impact factor: 3.575
  5 in total
  9 in total

1.  t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not.

Authors:  Albert G Tsai; Akinori Yoda; David M Weinstock; Michael R Lieber
Journal:  Blood       Date:  2010-09-16       Impact factor: 22.113

2.  Human lymphoid translocation fragile zones are hypomethylated and have accessible chromatin.

Authors:  Zhengfei Lu; Michael R Lieber; Albert G Tsai; Carolina E Pardo; Markus Müschen; Michael P Kladde; Chih-Lin Hsieh
Journal:  Mol Cell Biol       Date:  2015-01-26       Impact factor: 4.272

3.  Radical surgery may be not an optimal treatment approach for pulmonary MALT lymphoma.

Authors:  Liang Wang; Zhong-Jun Xia; Yu-Jing Zhang; Hui-Qiang Huang; Tong-Yu Lin; Yue Lu
Journal:  Tumour Biol       Date:  2015-03-24

4.  BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements.

Authors:  Zhengfei Lu; Albert G Tsai; Takashi Akasaka; Hitoshi Ohno; Yanwen Jiang; Ari M Melnick; Harvey A Greisman; Michael R Lieber
Journal:  Blood       Date:  2013-03-08       Impact factor: 22.113

5.  Both CpG methylation and activation-induced deaminase are required for the fragility of the human bcl-2 major breakpoint region: implications for the timing of the breaks in the t(14;18) translocation.

Authors:  Xiaoping Cui; Zhengfei Lu; Aya Kurosawa; Lars Klemm; Andrew T Bagshaw; Albert G Tsai; Neil Gemmell; Markus Müschen; Noritaka Adachi; Chih-Lin Hsieh; Michael R Lieber
Journal:  Mol Cell Biol       Date:  2012-12-21       Impact factor: 4.272

Review 6.  Mechanisms of human lymphoid chromosomal translocations.

Authors:  Michael R Lieber
Journal:  Nat Rev Cancer       Date:  2016-05-25       Impact factor: 60.716

7.  Ocular adnexal non-Hodgkin's lymphoma: a review of epidemiology and risk factors.

Authors:  Roxana Moslehi; Maria J Schymura; Seema Nayak; F Bruce Coles
Journal:  Expert Rev Ophthalmol       Date:  2011-04

8.  Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2V617F-myeloproliferative neoplasm.

Authors:  Katsuhiro Fukutsuka; Futoshi Iioka; Fumiyo Maekawa; Miho Nakagawa; Chiyuki Kishimori; Masahiko Hayashida; Shunsuke Tagawa; Takashi Akasaka; Gen Honjo; Hitoshi Ohno
Journal:  J Clin Exp Hematop       Date:  2021-05-14

9.  Mechanistic basis for chromosomal translocations at the E2A gene and its broader relevance to human B cell malignancies.

Authors:  Di Liu; Yong-Hwee Eddie Loh; Chih-Lin Hsieh; Michael R Lieber
Journal:  Cell Rep       Date:  2021-07-13       Impact factor: 9.423
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.